[go: up one dir, main page]

Drug Therapy, Combination

"Drug Therapy, Combination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

expand / collapse MeSH information
Therapy with two or more separate preparations given for a combined effect.


expand / collapse Publications
This graph shows the total number of publications written about "Drug Therapy, Combination" by people in this website by year, and whether "Drug Therapy, Combination" was a major or minor topic of these publications.
Below are the most recent publications written about "Drug Therapy, Combination" by people in Profiles.
  1. Long-term efficacy and safety of danicopan as add-on therapy to ravulizumab or eculizumab in PNH with significant EVH. Blood. 2025 Feb 20; 145(8):811-822.
    View in: PubMed
  2. Trial protocol of an open-label pilot study of oral naltrexone-bupropion combination pharmacotherapy for the treatment of methamphetamine use disorder (the NABU trial). BMJ Open. 2025 Feb 07; 15(2):e092032.
    View in: PubMed
  3. Lower Mortality Risk Associated With Remdesivir + Dexamethasone Versus Dexamethasone Alone for the Treatment of Patients Hospitalized for COVID-19. Clin Infect Dis. 2025 Feb 05; 80(1):63-71.
    View in: PubMed
  4. Selection and prioritization of candidate combination regimens for the treatment of tuberculosis. Sci Transl Med. 2025 Feb 05; 17(784):eadi4000.
    View in: PubMed
  5. Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis. N Engl J Med. 2025 Jan 30; 392(5):468-482.
    View in: PubMed
  6. Safety and efficacy of filgotinib in patients with rheumatoid arthritis: final results of the DARWIN 3 long-term extension study. RMD Open. 2025 Jan 30; 11(1).
    View in: PubMed
  7. Combination SGLT2 Inhibitor and Glucagon Receptor Antagonist Therapy in Type 1 Diabetes: A Randomized Clinical Trial. Diabetes Care. 2025 Jan 01; 48(1):52-60.
    View in: PubMed
  8. Diuretic Potentiation Strategies in Acute Heart Failure. JACC Heart Fail. 2025 Jan; 13(1):14-27.
    View in: PubMed
  9. AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis. Gastroenterology. 2024 Dec; 167(7):1307-1343.
    View in: PubMed
  10. Early combination therapy with SGLT2i and GLP-1 RA or dual GIP/GLP-1 RA in type 2 diabetes. Diabetes Obes Metab. 2025 Feb; 27(2):468-481.
    View in: PubMed